Seres Therapeutics Inc
MCRBLatest QuantConomy context for MCRB: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Seres Therapeutics Inc
QuantConomy has a structured record for MCRB. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- MCRB
- Name
- Seres Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq
Recent signals for MCRB
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| downtrend | bearish | 36 | Jul 10, 08:00 PM | MCRB downtrend (drop): price -1.78% (strength 36, current 6.07) |
| downtrend | very bearish | 100 | Jul 10, 06:04 PM | MCRB downtrend (drop): price -8.71% (strength 100, current 6.18) |
| downtrend | very bearish | 100 | Jul 9, 07:26 PM | MCRB downtrend (drop): price -6.39% (strength 100, current 6.74) |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| MCRB | NASDAQ | alphavantage | Seres Therapeutics Inc |
| MCRB | NASDAQ | alpaca | Seres Therapeutics, Inc. Common Stock |
| MCRB | NASDAQ | fmp | Seres Therapeutics, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Graves Kurt | Director | grant | 6,500 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Henn Matthew R | See Remarks | grant | 25,000 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Rosiello Robert L. | Director | grant | 6,500 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Brady Kelly | See Remarks | grant | 18,750 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Berenson Stephen | Director | grant | 6,500 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Fraser Claire | Director | grant | 6,500 | — | — | 4 on EDGAR |
| Jul 8, 2026 | DesRosier Thomas | See Remarks | grant | 7,500 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Ausiello Dennis A | Director | grant | 6,500 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Shaff Eric D. | Director | grant | 6,500 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Dere Willard H | Director | grant | 6,500 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Thorell Marella | See Remarks | grant | 7,500 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Kender Richard N | See Remarks | grant | 50,000 | — | — | 4 on EDGAR |
| Jul 1, 2026 | Berenson Stephen | Director | grant | 7,508 | — | — | 4 on EDGAR |
| Jul 1, 2026 | Rosiello Robert L. | Director | grant | 7,508 | — | — | 4 on EDGAR |
| May 15, 2026 | Brady Kelly | See Remarks | exercise | 180 | — | — | 4 on EDGAR |
| May 15, 2026 | Henn Matthew R | See Remarks | exercise | 238 | — | — | 4 on EDGAR |
| May 15, 2026 | DesRosier Thomas | See Remarks | exercise | 244 | — | — | 4 on EDGAR |
| May 15, 2026 | Shaff Eric D. | Director | exercise | 722 | — | — | 4 on EDGAR |
| Mar 4, 2026 | Brady Kelly | See Remarks | grant | 56,250 | — | — | 4 on EDGAR |
| Mar 4, 2026 | Kender Richard N | See Remarks | grant | 150,000 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query MCRB context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access